Cyclosporin-induced sebaceous hyperplasia in renal transplant patients

Annals of the Academy of Medicine Singapore

Volumn 34, Issue 5, 2005, Pages 391-393

  Pang, S M ^a   Chau, Y P ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Dysplasia; Immunosuppression

Indexed keywords

CYCLOSPORIN; PREDNISOLONE;

ADULT; ARTICLE; CANDIDA ALBICANS; CASE REPORT; CLINICAL FEATURE; EPSTEIN BARR VIRUS; GENETIC SUSCEPTIBILITY; HUMAN; HYPERPLASIA; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; LASER; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MUSCLE TUMOR; NAIL DYSTROPHY; ONYCHOLYSIS; ONYCHOMYCOSIS; SEBACEOUS GLAND; SKIN BIOPSY; SKIN DEFECT; TINEA CRURIS; TRICHOPHYTON RUBRUM; TUMOR GROWTH; VERRUCA VULGARIS;

EID: 22544472145     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Zouboulis CC, Boschnakow A. Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol 2001;26:600-7.
2. Dupre A, Bonafe JL, Lamon R. Functional familial sebaceous hyperplasia of the face. Reverse of the Cuncliffe acne-free naevus? Its inclusion among naevoid sebaceous receptor diseases. Clin Exp Dematol 1980;5:203-7.
3. Lugo-Janer G, Sanchez JL, Santiago-Delpin E. Prevalence and clinical spectrum of skin diseases in kidney transplant recipients. J Am Acad Dermatol 1991;3:410-4.
4. Bencini PL, Montagnino G, Sala F, De Vecchi A, Crosti C, Taratino A. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dematologica 1986;172:24-30.
5. Taylor AE, Shuster S. Skin cancer after renal tranplantation: the causal role of azathioprine. Acta Derm Venereol 1992;72:115-9.
6. Boschnakow A, May T, Assaf C, Tebbe B, Zouboulis ChC. Cyclosporin A-induced sebaceous gland hyperplasia. Br J Dermatol 2003;149: 198-200.
7. de Berker DA, Taylor AE, Quinn AG, Simpson NB. Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes? J Am Acad Dermatol 1996;35:696-9.
8. Spaun E, Arffmann E. Promotion pattern and tumour types in two-stage rat skin carcinogenesis. Cancer Lett 1992;65:151-8.
9. Marini M, Saponaro A, Remorino L, Lynch P, Magarinos G. Eruptive lesions in a patient with bone marrow transplanation. Int J Dermatol 2001;40:133-5.
10. Ost L. Effects of cyclosporin on prednisolone metabolism. Lancet 1984;1:451.
11. Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV, et al. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 2001;116:246-53.
12. Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJ. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 2000;6:1784-9.
13. Niederberger W, Lemaire M, Maurer G, Nussbaumer K, Wagner O. Distribution and binding of cyclosporin in blood and tissues. In: Kahan BD, editor. Cyclosporin: Biological Activity and Clinical Applications. USA: Grune & Stratton, 1984;203-5.
14. Grimait R, Ferrando J, Mascaro JM. Premature familial sebaceous hyperplasia: successful response to oral isotretinoin in three patients. J Am Acad Dermatol 1997;37:996-8.
15. Walter T, Hohenleutner U, Landthaler M. Sebaceous gland hyperplasia as a side effect of cyclosporin A treatment with CO2 laser (German). Dtsch Med Wochenschr 1986;123:789-800.